Retatrutide 40mg

Retatrutide is a synthetic peptide that simultaneously activates the GLP-1, GIP and glucagon receptors, producing combined incretin and glucagon-axis engagement in a single molecule. This triple-agonist mechanism underpins its role in research into metabolic flexibility, energy expenditure and pancreatic hormone signalling, and has established it as one of the most-studied triple agonists in modern metabolic research.

This 40mg lyophilised peptide vial is supplied for reconstitution with bacteriostatic water and is intended for extended research protocols, larger animal models and institutional laboratories where higher per-vial quantities reduce handling overhead and improve unit cost across long-running comparative studies.

Research Applications • Long-duration studies of triple receptor signalling and metabolic adaptation • High-throughput screening of GLP-1, GIP and glucagon agonist activity • Extended in vivo investigations of body composition and energy balance • Reference standard work in comparative incretin and glucagon pharmacology

Specification • Identity: Retatrutide (CAS 2381089-83-2) • Molecular weight: 4875.42 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.